Home LiteratureArticle Details
PMID: 8794384 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection.

Journal of virology ·Vol. 70 ·No. 10 ·1996-10-00 ·Pages 7285-9

Ferbas J, Daar ES, Grovit-Ferbas K, Lech WJ, Detels R, Giorgi JV, Kaplan AH

Abstract

The relationship between host and virus was examined during the initial stages of human immunodeficiency virus type 1 (HIV) infection in a volunteer from the Multicenter AIDS Cohort Study (MACS). The individual was asymptomatic and unaware of his infection during an initial donation of blood and inguinal lymphoid tissue. Proviral DNA, however, was present in cells from both sources, HIV RNA was detected in the plasma, and CD4+ cell levels were reduced by approximately 50% compared with previous donations in the MACS. In a second blood donation 12 days later, plasma HIV RNA increased 200-fold in tandem with viral isolates with an increased growth phenotype in vitro. HIV burden was ultimately suppressed upon seroconversion and the emergence of HIV-specific CD8+ cytotoxic T lymphocytes. These observations provide further evidence that the potential benefits of early treatment may be maximized during the early stages of infection, when viral fitness may be low but is unopposed by immune responses.

MeSH Terms
CD4-Positive T-Lymphocytes/immunology CD8-Positive T-Lymphocytes/immunology HIV Infections/blood,immunology,virology HIV Seronegativity HIV-1 Humans Viral Load Virus Replication
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Ferbas J
Department of Medicine, University of California at Los Angeles 90095, USA.
Daar E S
Grovit-Ferbas K
Lech W J
Detels R
Giorgi J V
Kaplan A H
References (31)
31 references, click to expand
  1. Risk of developing AIDS after primary acute HIV-1 infection.
    J Acquir Immune Defic Syndr. 1993 Jun;6(6):575-81 PMID: 8098750
  2. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up.
    Cytometry. 1996 Mar 15;26(1):1-7 PMID: 8809474
  3. Genotypic and phenotypic characterization of HIV-1 patients with primary infection.
    Science. 1993 Aug 27;261(5125):1179-81 PMID: 8356453
  4. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection.
    J Clin Microbiol. 1994 Feb;32(2):364-70 PMID: 7908672
  5. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression.
    J Virol. 1994 Jul;68(7):4400-8 PMID: 7515972
  6. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
    J Virol. 1994 Jul;68(7):4650-5 PMID: 8207839
  7. Development of the anti-gp120 antibody response during seroconversion to human immunodeficiency virus type 1.
    J Virol. 1994 Aug;68(8):5142-55 PMID: 8035514
  8. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.
    J Virol. 1994 Sep;68(9):6103-10 PMID: 8057491
  9. Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression.
    J Virol. 1994 Oct;68(10):6634-43 PMID: 7916061
  10. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays.
    J Virol. 1994 Oct;68(10):6672-83 PMID: 8084001
  11. Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmission.
    J Clin Invest. 1994 Nov;94(5):2060-7 PMID: 7962552
  12. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.
    J Virol. 1995 Mar;69(3):1810-8 PMID: 7853521
  13. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.
    Ann Intern Med. 1995 Apr 15;122(8):573-9 PMID: 7887550
  14. Characterization of human granular lymphocyte subpopulations expressing HNK-1 (Leu-7) and Leu-11 antigens in the blood and lymphoid tissues from fetuses, neonates and adults.
    Eur J Immunol. 1984 Jul;14(7):616-23 PMID: 6430709
  15. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.
    Am J Epidemiol. 1987 Aug;126(2):310-8 PMID: 3300281
  16. Quality control in the flow cytometric measurement of T-lymphocyte subsets: the multicenter AIDS cohort study experience. The Multicenter AIDS Cohort Study Group.
    Clin Immunol Immunopathol. 1990 May;55(2):173-86 PMID: 1969782
  17. Primary HIV infection: host responses and intervention strategies.
    AIDS. 1991 Jan;5(1):1-14 PMID: 1812848
  18. Lymphoid organs function as major reservoirs for human immunodeficiency virus.
    Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9838-42 PMID: 1682922
  19. Rapid generation of sequence variation during primary HIV-1 infection.
    AIDS. 1992 May;6(5):453-60 PMID: 1616650
  20. Detection of plasma viremia in human immunodeficiency virus-infected individuals at all clinical stages.
    J Clin Microbiol. 1993 Feb;31(2):283-8 PMID: 8094395
  21. Predictors of rapid progression to AIDS in HIV-1 seroconverters.
    AIDS. 1993 Jan;7(1):51-7 PMID: 8095146
  22. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals.
    J Virol. 1993 Apr;67(4):1772-7 PMID: 8095306
  23. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    J Immunol. 1993 Apr 1;150(7):3070-9 PMID: 8454874
  24. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.
    Nature. 1993 Mar 25;362(6418):355-8 PMID: 8455722
  25. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.
    Nature. 1993 Mar 25;362(6418):359-62 PMID: 8096068
  26. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection.
    J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jul 1;9(3):305-10 PMID: 7788430
  27. A controlled trial of zidovudine in primary human immunodeficiency virus infection.
    N Engl J Med. 1995 Aug 17;333(7):408-13 PMID: 7616989
  28. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity.
    J Infect Dis. 1995 Aug;172(2):329-39 PMID: 7622874
  29. Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine.
    Science. 1995 Nov 17;270(5239):1197-9 PMID: 7502044
  30. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma.
    Science. 1996 May 24;272(5265):1167-70 PMID: 8638160
  31. V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability.
    J Virol. 1993 Sep;67(9):5623-34 PMID: 8350415
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1996-10-00
Pages
7285-9
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC190790
Subset
IM
Grants
NIAID NIH HHS · AI35040 · United States
NIAID NIH HHS · AI37604 · United States
NIAID NIH HHS · AI37613 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com